EUROFINS : Barclays downgrades to 'online weighted'.
In a sector study, the analyst acknowledges that the stock is currently the best performer in the analysis, inspection and certification market, and that the case looks promising now that the evolution of the perimeter has been sealed after years of acquisitions, which should support margins and cash flow.
However, the intermediary explains that he prefers to wait for a real improvement in free cash flow, in line with the targets set by the management team, before being positive on the stock, recalling that the bio-analysis group has a habit of disappointing market expectations.
Copyright (c) 2025 CercleFinance.com. All rights reserved.
The information and analyses published by Cercle Finance are intended solely as a decision-making aid for investors. Cercle Finance cannot be held responsible, directly or indirectly, for the use of information and analyses by readers. Uninformed investors are advised to consult a professional advisor before investing. This information does not constitute an invitation to sell or a solicitation to buy.
Go to the original article.
Contact us to request a correction